NCT05879146View on ClinicalTrials.gov

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

PHASE2RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions

Tumor

Interventions

DRUG

Nirogacestat

Given by PO

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

SpringWorks Therapeutics, Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER